International Electronic Patient Registry: Clinical Experience With Polyfocal Bioanalogic IOL
Narrative Responses:
Purpose
Clinical evaluation of functional results and quality of vision after bilateral implantation of a bioanalogic, polyfocal, accommodative intraocular lens WIOL-CF
Methods
The WIOL-CF bioanalogic, polyfocal, accommodative IOL (MEDICEM) were implanted bilaterally after phacoemulsification with max. 2 weeks between the first and second eye implantation. Patient with any other ophthalmic pathology were excluded. Follow-up examinations were performed two weeks and three months after surgery including uncorrected and corrected visual acuity (VA) for far, near and intermediate distances, subjective refraction. The quality of vision, glare, halos, spectacle independence and the personal satisfaction of the patients was assessed with a questionnaire.
Results
38 cataract patients with 3 month data (76 eyes) from 8 participating centres from 7 countries have been evaluated in this non-interventional, multicentre, prospective observational registry. Mean age 59.9 years, median 59.5 years.
Three months after implantation mean uncorrected distance VA was 1.1 (decimal) and 100% of patients are better than 0.9. Mean uncorrected near VA J2.6 and intermediate VA J1,3.
97% patients did not need glasses for daily activities, driving and reading and 100% expressed subjective satisfaction. Any patient did not report serious/disturbing optical phenomena, only 13% reported mild glare/halo.
Conclusion
The WIOL-CF IOL provides very good and predictable functional results after surgery and should be considered as very promising IOL for refractive and cataract surgery, correcting presbyopia.